Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion type Assertion NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_head.
- NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion description "[There is an increased risk of CML in subjects with (i) deletions of genes encoding glutathione-S-transferase (GST)-?1 (GSTT1) and -?1, (GSTM1) and (ii) the GST-?1 (GSTP1) single-nucleotide polymorphism (SNP) Ile105Val (GSTP1*B; rs1695); however, their effects on imatinib treatment outcome are not known.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_provenance.
- NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion evidence source_evidence_literature NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_provenance.
- NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion SIO_000772 25188725 NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_provenance.
- NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion wasDerivedFrom befree-20150227 NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_provenance.
- NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_assertion wasGeneratedBy ECO_0000203 NP971375.RA0UmN8c5jk1irgyjyCt0dYTzTnbl34a7mYjiHC-ZbWnI130_provenance.